Belimumab Recruiting Phase 4 Trials for Systemic Lupus Erythematosus Prevention

IndicationsStatusPurposePhase
RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT04515719Efficacy and Safety of Belimumab in SLE Patients